KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $72.7 million.

  • West Pharmaceutical Services' Shares Outstanding (Diluted Average) fell 149.05% to $72.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.7 million, marking a year-over-year decrease of 149.05%. This contributed to the annual value of $73.7 million for FY2024, which is 212.48% down from last year.
  • Latest data reveals that West Pharmaceutical Services reported Shares Outstanding (Diluted Average) of $72.7 million as of Q3 2025, which was down 149.05% from $72.8 million recorded in Q2 2025.
  • West Pharmaceutical Services' Shares Outstanding (Diluted Average)'s 5-year high stood at $76.3 million during Q4 2021, with a 5-year trough of $72.7 million in Q3 2025.
  • In the last 5 years, West Pharmaceutical Services' Shares Outstanding (Diluted Average) had a median value of $75.5 million in 2023 and averaged $74.9 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Shares Outstanding (Diluted Average) skyrocketed by 65.96% in 2021, and later tumbled by 225.17% in 2024.
  • West Pharmaceutical Services' Shares Outstanding (Diluted Average) (Quarter) stood at $76.3 million in 2021, then fell by 0.66% to $75.8 million in 2022, then dropped by 0.66% to $75.3 million in 2023, then decreased by 2.12% to $73.7 million in 2024, then dropped by 1.36% to $72.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $72.7 million for Q3 2025, versus $72.8 million for Q2 2025 and $73.0 million for Q1 2025.